ARCHIVES

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

This article is from The Cancer Letter archive.

Vol. 29 No. 25 | June 20, 2003

Download PDF Visit The Full Archive

Related Articles

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

NSABP Researcher Committed Misconduct, NIH Investigation Finds

March 18, 1994

Advocacy Groups Consider Pros And Cons Of Forming Co-Pay Foundations.

April 28, 2006

Bach: LCA Center Certification Untrustworthy; CISNET Models Don’t Match

May 9, 2014

NCI CTEP-Approved Trials For the Month of July

July 25, 2014

Senate Subcommittee Oks $850Million for Cancer; NCI Reveals How It Would Spend Fiscal 1978 Funds

June 18, 1976